Ibandroninezuur CT 150 mg, filmomhulde tabletten

Illustratie van Ibandroninezuur CT 150 mg, filmomhulde tabletten
Stof(fen) Ibandroninezuur
Toelating Nederland
Producent Teva
Verdovend Nee
ATC-Code M05BA06
Farmacologische groep Geneesmiddelen die botstructuur en mineralisatie beïnvloeden

Vergunninghouder

Teva

Geneesmiddelen met dezelfde werkzame stof

Medicijn Stof(fen) Vergunninghouder
Ibandroninezuur Avansor 150 mg, filmomhulde tabletten Ibandroninezuur Avansor Pharma
Ibandroninezuur Xiromed 150 mg filmomhulde tabletten Ibandroninezuur Medical Valley Invest AB Brädgardsvägen 28 23632 HÖLLVIKEN (ZWEDEN)
Bonviva 150 mg filmomhulde tabletten Ibandroninezuur Atnahs Pharma Netherlands B.V.
Ibandroninezuur Lincosa 150 mg Filmomhulde tabletten Ibandroninezuur Laboratorios Liconsa
Ibandroninezuur STADA 150 mg, filmomhulde tabletten Ibandroninezuur Stada

Brochure

Waarvoor wordt dit middel gebruikt?

1. What is and what it is used for

<Ibandronic acid 150 mg> belongs to a group of medicines calledbisphosphonates. It contains ibandronic acid. It does not contain hormones.

<Ibandronic acid 150 mg> may reverse bone loss by stopping more loss of bone and increasing bone mass in most women who take it, even though they won’t be able to see or feel a difference. <Ibandronic acid 150 mg> may help lower the chances of breaking bones (fractures). This reduction in fractures was shown for the spine but not for the hip.

<Ibandronic acid 150 mg> is prescribed to you to treat postmenopausal osteoporosis because you have an increased risk of fractures. Osteoporosis is a thinning and weakening of the bones, which is common in women after the menopause. At the menopause, a woman’s ovaries stop producing the female hormone, oestrogen, which helps to keep her skeleton healthy.

The earlier a woman reaches the menopause, the greater her risk of fractures in osteoporosis. Other things that can increase the risk of fractures include:

  • not enough calcium and vitamin D in the diet
  • smoking, or drinking too much alcohol
  • not enough walking or other weight-bearing exercise
  • a family history of osteoporosis

Many people with osteoporosis have no symptoms. If you have no symptoms you may not know if you have the condition. However, osteoporosis makes you more likely to break bones if you fall or hurt yourself. A broken bone after the age of 50 may be a sign of osteoporosis. Osteoporosis can also cause back pain, height loss and a curved back.

<Ibandronic acid 150 mg> prevents loss of bone from osteoporosis, and helps to rebuild bone. Therefore <Ibandronic acid 150 mg> makes bone less likely to break.

A healthy lifestyle will also help you to get the most benefit from your treatment. This includes eating a balanced diet rich in calcium and vitamin D; walking or any other weight-bearing exercise; not smoking; and not drinking too much alcohol.

Advertentie

Wanneer mag u dit middel niet gebruiken of moet u er extra voorzichtig mee zijn?

2. What you need to know before you take

Do not take <Ibandronic acid 150 mg>:

  • if you are allergic (hypersensitive) to ibandronic acid or any of the other ingredients of this medicine (listed in section 6).
  • if you have certain problems with your oesophagus (the tube connecting your mouth with your stomach) such as narrowing or difficulty swallowing.
  • if you can’t stand or sit upright for at least one hour (60 minutes) at a time.
  • If you have, or had in the past low blood calcium. Please consult your doctor.

Children and teenagers

Do not give <Ibandronic acid 150 mg> to children or teenagers.

Take special care with <Ibandronic acid 150 mg>

Some people need to be especially careful while they’re taking <Ibandronic acid 150 mg>. Check with your doctor:

  • If you have any disturbances of mineral metabolism (such as vitamin D deficiency).
  • If your kidneys are not functioning normally.
  • If you have any swallowing or digestive problems.
    • If you are under dental treatment or will undergo dental surgery, tell your dentist that you are being treated with <Ibandronic acid 150 mg>.

Irritation, inflammation or ulceration of the oesophagus (the tube connecting your mouth with your stomach) often with symptoms of severe pain in the chest, severe pain after swallowing food and/or drink, severe nausea, or vomiting may occur, especially if you do not drink a full glass of plain water and/or if you lie down within an hour of taking <Ibandronic acid 150 mg>. If you develop these symptoms, stop taking <Ibandronic acid 150 mg> and tell your doctor straight away.

Taking other medicines

Please tell your doctor or pharmacist if you are taking, or have recently taken any other medicines, including medicines obtained without prescription. Especially:

Supplements- containing calcium, magnesium, iron or aluminium, as they could possibly influence the effects of <Ibandronic acid 150 mg>.

  • Aspirin and other non-steroidal anti-inflammatory medicines (NSAIDs) ( including ibuprofen, diclofenac sodium and naproxen) may irritate the stomach and intestine. Bisphosphonates (like <Ibandronic acid 150 mg>) may also do so. So be especially careful if you take painkillers or anti-inflammatories while you’re taking <Ibandronic acid 150 mg>.

After swallowing your monthly <Ibandronic acid 150 mg> tablet, wait for 1 hour before taking any other medication, including indigestion tablets, calcium supplements, or vitamins.

<Ibandronic acid 150 mg> with food and drink

Do not take <Ibandronic acid 150 mg> with food. <Ibandronic acid 150 mg> is less effective if it’s taken with food.

You can drink plain water but no other drinks (see 3. How to take <Ibandronic acid 150 mg>).

Pregnancy and breast-feeding

Do not take <Ibandronic acid 150 mg> if you’re pregnant or breast feeding. If you’re breast feeding, you may need to stop in order to take <Ibandronic acid 150 mg>.

Ask your doctor or pharmacist for advice before taking any medicines.

Driving and using machines

You can drive and use machines as it’s very unlikely that <Ibandronic acid 150 mg> will affect your ability to drive and use machines.

Important information about some of the ingredients of <Ibandronic acid 150 mg>

<Ibandronic acid 150 mg> contains an ingredient called lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

Advertentie

Hoe gebruikt u dit middel?

3. How to take

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The usual dose of <Ibandronic acid 150 mg> is one tablet once a month.

Taking your monthly tablet

It’s important to follow these instructions carefully. They are designed to help your <Ibandronic acid 150 mg> tablet reach your stomach quickly, so it’s less likely to cause irritation.

  • Take one <Ibandronic acid 150 mg> tablet once a month.
  • Choose one day of the month that will be easy to remember. You can choose either the same date (such as the 1st of each month) or the same day (such as the first Sunday of each month) to take your <Ibandronic acid 150 mg> tablet. Choose the date that best fits your routine.
  • Take your <Ibandronic acid 150 mg> tablet at least 6 hours after you last had anything to eat or drink except plain water.
  • Take your <Ibandronic acid 150 mg> tablet

after- you first get up for the day, and

before- you have anything to eat or drink (on an empty stomach)

  • Swallow your tablet with a full glass of plain water (at least 180 ml).

Dotake your tabletnot with mineral water, fruit juice or any other drinks.

  • Swallow your tablet whole — do not chew it, crush it or let it dissolve in your mouth.
  • For the next hour (60 minutes) after you’ve taken your tablet

do- not lie down; if you do not stay upright (standing or sitting), some of the medicine could leak back into your oesophagus

  • do not eat anything
  • do not drink anything (except plain water if you need it)
    • do not take any other medicines
  • After you’ve waited for an hour, you can have your first food and drink of the day. Once you’ve eaten, it’s OK to lie down if you wish, and to take any other medication you need.

Do not take your tablet at bedtime or before you get up for the day.

Continuing to take <Ibandronic acid 150 mg>

It’s important to keep taking <Ibandronic acid 150 mg> every month, as long as your doctor prescribes it for you.

<Ibandronic acid 150 mg> can treat osteoporosis only as long as you keep taking it.

If you take too much <Ibandronic acid 150 mg>

If you’ve taken more than one tablet by mistake, drink a full glass of milk and talk to your doctor straight away.

Do not make yourself vomit, and do not lie down — this could cause <Ibandronic acid 150 mg> to irritate your oesophagus.

If you forget a dose

If you forget to take your tablet on the morning of your chosen day, do not take a tablet later in the day. Instead, consult your calendar and find out when your next scheduled dose is:

If your next scheduled dose is only 1 to 7 days away…

You should wait until the next scheduled dose is due and take it as normal; then, continue taking one tablet once a month on the scheduled days you’ve marked on your calendar.

If your next scheduled dose is more than 7 days away…

You should take one tablet the next morning after the day you remember; then, continue taking one tablet once a month on the scheduled days you’ve marked on your calendar.

Never take two <Ibandronic acid 150 mg> tablets within the same week.

Advertentie

Mogelijke bijwerkingen?

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Talk to a nurse or a doctor straight away if you notice any of the following serious side effects - you may need urgent medical treatment:

  • rash, itching, swelling of your face, lips, tongue and throat, with difficulty breathing. You may be having an allergic reaction to the medicine.
  • severe pain in the chest, severe pain after swallowing food or drink, severe nausea, or vomiting.
  • flu-like symptoms (if any effects become troublesome or last more than a couple of days).
  • pain or sore in your mouth or jaw
  • eye pain and inflammation (if prolonged)

Other possible side effects

Common (affects less than 1 in 10 people)

  • headache
  • heartburn, stomach pain (such as “gastroenteritis” or “gastritis”), indigestion, nausea, having diarrhoea or constipation
  • rash
  • pain or stiffness in your muscles, joints, or back
  • flu-like symptoms (including fever, shaking and shivering, feeling of discomfort, fatigue, bone pain and aching muscles and joints)
  • fatigue

Uncommon (affects less than 1 in 100 people)

  • bone pain
  • feeling weak
  • dizziness
  • flatulence

Rare (affects less than 1 in 1000 people):

  • hypersensitivity reaction; swelling of the face, lips and mouth (see allergy)
  • itching
  • eye pain or inflammation
  • unusual fracture of the thigh bone particularly in patients on long-term treatment for osteoporosis may occur rarely. Contact your doctor if you experience pain, weakness or discomfort in your thigh, hip or groin as this may be an early indication of a possible fracture of the thigh bone.

Very rare (affects less than 1 in 10000 people)

  • a condition involving exposed bone in the mouth called “osteonecrosis of the jaw”.

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Advertentie

Hoe bewaart u dit middel?

5. How to store

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton after “EXP”. The expiry date refers to the last day of that month.

This medicinal product does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

Advertentie

Anvullende Informatie

What <Ibandronic acid 150 mg> contains

The active substance is 150 mg of ibandronic acid.

The other ingredients are lactose monohydrate, crospovidone (E1202), microcrystalline cellulose (E460), colloidal anhydrous silica (E551), sodium stearyl fumarate (tablet core); polyvinyl alcohol, macrogol/PEG 3350, talc (E553b) and titanium dioxide (E171) (tablet coating).

What <Ibandronic acid 150 mg> looks like and contents of the pack

Ibandronic acid tablets are white to off-white, oblong tablets inscripted with “I9BE” on one side and “150” on the other side.

They are available in blister packs off 1, 3, 7, 10 or 14 tablets. (NL/H/1831-1833)

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Teva Pharma B.V. Computerweg 10 3542 DR Utrecht Nederland

Manufacturer

Synthon BV

Microweg 22

6545 CM Nijmegen

Nederland

Synthon Hispania

Castello 1, Poligono las Salinas 08830 Sant Boi de Llobregat Spanje

Merckle GmbH

Ludwig-Merckle Strasse 3

89143 Blaubeuren-Weiler

Duitsland

Dit geneesmiddel is geregistreerd onder

Ibandroninezuur CT 150 mg, filmomhulde tabletten RVG 106020

Dit geneesmiddel is geregistreerd in lidstaten van de EEA onder de volgende namen:

Duitsland (DE) Ib andronsäure-CT 150 mg Filmtabletten
Nederland (NL) Ib androninezuur CT 150 mg, filmom

This leaflet was last revised in oktober 2013.

Advertentie

Stof(fen) Ibandroninezuur
Toelating Nederland
Producent Teva
Verdovend Nee
ATC-Code M05BA06
Farmacologische groep Geneesmiddelen die botstructuur en mineralisatie beïnvloeden

Delen

Advertentie

Uw persoonlijke medicijn-assistent

afgis-Qualitätslogo mit Ablauf Jahr/Monat: Mit einem Klick auf das Logo öffnet sich ein neues Bildschirmfenster mit Informationen über medikamio GmbH & Co KG und sein/ihr Internet-Angebot: medikamio.com/ This website is certified by Health On the Net Foundation. Click to verify.
Medicijnen

Zoek hier onze uitgebreide database van medicijnen van A-Z, met effecten en ingrediënten.

Stoffen

Alle werkzame stoffen met hun toepassing, chemische samenstelling en medicijnen waarin ze zijn opgenomen.

Ziekten

Oorzaken, symptomen en behandelingsmogelijkheden voor veel voorkomende ziekten en verwondingen.

De getoonde inhoud komt niet in de plaats van de oorspronkelijke bijsluiter van het geneesmiddel, met name wat betreft de dosering en de werking van de afzonderlijke producten. Wij kunnen niet aansprakelijk worden gesteld voor de juistheid van de gegevens, aangezien deze gedeeltelijk automatisch zijn omgezet. Voor diagnoses en andere gezondheidskwesties moet altijd een arts worden geraadpleegd. Meer informatie over dit onderwerp vindt u hier.